TNON · Tenon Medical, Inc.
$0.21
+0.01 (+3.98%)
At close · Jul 20
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the uncertainty in our ability to raise capital, management believes that there is substantial doubt in our ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$2.42M
Shares
11.57M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.94M
+20.4%
FY2025
Net Income
-$12.56M
+8.2%
FY2025
Gross Margin
59.79%
+7.6pp
FY2025
Operating Margin
-324.34%
+95.7pp
FY2025
Diluted EPS
-$1.70
+84.9%
FY2025
Operating Cash Flow
-$10.75M
-8.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $4.6M | $3.94M | $3.28M | $2.93M | $691K | $160K | |
| — | — | — | $2.25M | — | — | |
| $1.62M | $1.59M | $1.57M | $1.69M | $1.33M | $55K | |
| $2.98M | $2.36M | $1.71M | $1.24M | -$641K | $105K | |
| — | 59.79% | 52.21% | 42.38% | -92.76% | 65.62% | |
| $2.12M | $2.15M | $2.6M | $3.16M | $2.83M | $1.72M | |
| $6.24M | $6.03M | $5.11M | $6.78M | $7.83M | $2.14M | |
| $7.02M | $6.98M | $7.77M | $7.03M | $7.42M | $2.71M | |
| — | $262K | $408K | $199K | $78K | — | |
| $15.38M | $15.15M | $15.48M | $16.97M | $18.08M | $6.57M | |
| -$12.4M | -$12.79M | -$13.77M | -$15.73M | -$18.73M | -$6.46M | |
| — | -324.34% | -420.08% | -537.12% | -2709.84% | -4038.12% | |
| — | -$12.53M | -$13.36M | -$15.53M | -$18.65M | — | |
| — | — | $34K | $21K | $354K | — | |
| -$21K | $236K | $93K | $146K | -$192K | -$620K | |
| $200K | $236K | $183K | $167K | $180K | $2000 | |
| — | — | — | — | -$18.92M | -$7.08M | |
| -$12.42M | -$12.56M | -$13.67M | -$15.58M | -$18.92M | -$7.05M | |
| — | -318.36% | -417.24% | -532.14% | -2737.63% | -4405% | |
| — | — | — | — | $0 | -$33K | |
| — | -$12.56M | -$13.63M | -$15.53M | -$18.93M | -$7.05M | |
| USD/shares | — | -$1.70 | -$11.26 | -$68.64 | -$188.96 | -$624.80 |
| USD/shares | — | -$1.70 | -$11.26 | -$68.64 | -$188.96 | -$624.80 |
| shares | — | 7384 | 1214 | 227 | 100.125 | 11.2875 |
| shares | — | 7384 | 1214 | 227 | 100.125 | 11.2875 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.36×
P/E (TTM)
—
Medical Devices median 27.81×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2024 |
|---|---|
| All Other Segments | $3,277,000 |